InvestorsHub Logo

Northstar42

01/21/17 8:20 AM

#9589 RE: Pyrrhonian #9588

I have no problem with current CYDY Management Team, as they have thus far guided PRO 140 through the trials and pitfalls of the FDA gauntlet reasonably well. Whether or not CYDY becomes a successful investment for shareholders will now depend on the Clinical Results of the Phase3 Trials. Based on earlier trial results and current reports, it appears the chances of success are excellent.

buckysherm

01/21/17 10:38 AM

#9590 RE: Pyrrhonian #9588

The bearish case is that they will show efficacy in 2 months and be bought out for $2 billion

5TOP

01/21/17 4:17 PM

#9594 RE: Pyrrhonian #9588

Not really. And what there is I wouldn't call a "good case". But like any investment there are risks and unknowns. We have a few posters that pretty consistently post negative/bearish comments, although they insist they aren't "bears", probably because they think it gives them more credibility. Anyway, in my opinion there are a few valid points and a lot of babble so you will probably just have to read through them.